Results 21 to 30 of about 1,015,018 (167)
ENDOGENOUS BETA-ADRENERGIC RECEPTOR ANTAGONISTS (EBARA) IN HEALTH AND DISEASE [PDF]
Data accumulated in investigations under in vivo and in vitro conditions confirm author's concept about the existence of EBARA, certain endogenous biologically active substances in a healthy and pathologically altered organism when no betaadrenergic ...
Temnyalov, N.
core +1 more source
Adrenergic control of human fat cell lipolysis is mediated by two kinds of receptor sites that are simultaneously stimulated by physiological amines. To establish a correlation between the binding characteristics of the receptor and biological functions,
M Lafontan, M Berlan, A Villeneuve
doaj +1 more source
Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma
Human angiosarcomas and canine hemangiosarcomas are highly aggressive cancers thought to arise from cells of vascular origin. The pathological features, morphological organization, and clinical behavior of canine hemangiosarcomas are virtually ...
Erin B. Dickerson, Brad A. Bryan
doaj +1 more source
Objective: Cancer therapy may cause cardiovascular toxicity even after successful treatment. It is unknown the cardioprotective role of carvedilol in this setting.
Lucía Florio Legnani +2 more
doaj +1 more source
Background Previous research has indicated that at various organ sites there is a subset of adenocarcinomas that is regulated by beta-adrenergic and arachidonic acid-mediated signal transduction pathways.
Cakir Yavuz +3 more
doaj +1 more source
Background There is no proven primary preventive strategy for doxorubicin‐induced subclinical cardiotoxicity (DISC), especially among patients without a cardiovascular (CV) risk.
Myunhee Lee +6 more
doaj +1 more source
Beta adrenergic antagonists and antianginal drugs
Beta adrenergic antagonists and antianginal drugs are used with the aim to ultimately decrease mortality and enable patients to lead an improved quality of life by avoidance of anginal episodes.
Stever, Lindsey M. +9 more
core +1 more source
Beta‐blocker usage is inconsistently associated with increased fall risk in the literature. However, due to age‐related changes and interindividual heterogeneity in pharmacokinetics and dynamics, it is difficult to predict which older adults are more at ...
K. J. Ploegmakers +11 more
doaj +1 more source
Management of Hypertrophic Obstructive Cardiomyopathy with Concurrent Hypertension and Intracerebral Haemorrhage: A Case Report [PDF]
Hypertrophic Obstructive Cardiomyopathy (HOCM) is primarily a hereditary genetic disorder that presents difficulties in managing hypertension using a wide range of antihypertensive medications.
Sangram Mangudkar +4 more
doaj +1 more source
Co-Crystallization Adducts of Carvedilol with Carboxylic Acids: Design and Characterization
Carvedilol (CARV) belongs to the group of non-selective beta and alpha-1 adrenergic receptor antagonists and is indicated for hypertension and chronic heart failure [...]
Ema-Teodora Nițu +7 more
doaj +1 more source

